Zeev Sohn

Title: Zeev Sohn: Innovator in Prostate Treatment

Introduction

Zeev Sohn is a notable inventor based in Ginot Shomron, Israel. He has made significant contributions to the field of medical technology, particularly in the treatment of benign prostatic hyperplasia (BPH). His innovative approach has led to the development of a unique patent that addresses prostatic obstruction.

Latest Patents

Zeev Sohn holds a patent for the "Transurethral Volume Reduction of the Prostate" (TUVOR). This process is designed to reduce or relieve prostatic obstruction through a series of carefully orchestrated steps. The TUVOR process includes transurethral incision, de-bulking and intra-prostatic volume reduction, and intra-prostatic void exclusion. Additionally, it involves space filling with adhesive and/or therapeutic polymeric materials, which may include bioactive agents and mechanical means for closure. The final steps consist of endourethral compression and prostatic mass remolding, culminating in the application of an endourethral polymer liner layer. This liner, made from structurally supportive yet biodegradable polymers, supports the urethra and peri-urethral tissue during healing, potentially eliminating the need for post-procedure catheter drainage. The TUVOR process is designed to allow outpatient treatment under local anesthesia for BPH.

Career Highlights

Throughout his career, Zeev Sohn has worked with various companies, including Harmonia Medical Technologies, Inc. and Syneron Medical Ltd. His work has focused on advancing medical technologies that improve patient outcomes and enhance treatment options for common health issues.

Collaborations

Zeev Sohn has collaborated with esteemed professionals in the field, including Marvin J. Slepian and Daniel Yachia. These collaborations have contributed to the development and refinement of his innovative medical solutions.

Conclusion

Zeev Sohn's contributions to the field of medical technology, particularly through his patent for the TUVOR process, highlight his commitment to improving healthcare solutions for patients suffering from prostatic obstruction. His work exemplifies the impact of innovation in medicine and the importance of collaboration in advancing treatment methodologies.